Medical News

RSS

NeuroVision Imaging receives ADDF funding to develop biomarker tests for Alzheimer's disease

NeuroVision Imaging Inc., announced today it has received an investment from the Alzheimer's Drug Discovery Foundation to support developing reliable, affordable biomarker tests for Alzheimer's disease and other forms of dementia and neurodegenerative disorders.

3 Feb 2021

Insight into role of aging in response to SARS-CoV-2 infection

Researchers at the University of California, Irvine set out to determine the differences between young people and older adults regarding their host responses against SARS-CoV-2. The team revealed that independent of disease severity, COVID-19 was linked to a significant shift in plasma inflammatory factors. The research is posted to the pre-print server medRxiv*.

3 Feb 2021

Newly launched medical truck brings the emergency room to cardiac arrest patients

University of Minnesota, The Leona M. and Harry B. Helmsley Charitable Trust and health care system partners announce the launch of a truck outfitted with medical equipment and virtual reality technology to help experts attend to patients remotely for extracorporeal membrane oxygenation (ECMO).

3 Feb 2021

Rescheduling drugs can reduce use as well as the dangers, study finds

Many nations place drugs into various schedules or categories according to their risk of being abused and their medical value.

3 Feb 2021

New drug cocktail offers hope to patients with highly drug-resistant tuberculosis

A new three-drug, all-oral, six-month treatment is providing hope to patients in Tajikistan with highly drug-resistant forms of tuberculosis, which until now had limited treatment options and poor prognosis.

3 Feb 2021

COVID-19 vaccine should be recommended to patients with Parkinson’s disease, experts say

Patients with Parkinson's disease (PD) and healthcare professionals caring for them have expressed concerns about the COVID-19 vaccine's efficacy and safety in the specific context of PD and its symptomatic treatment.

3 Feb 2021

Exploring the living quality in high-density housing

When we build new apartment block developments, we have to weigh up a number of factors, such as the number of apartments, their layouts, and access to light and a view.

3 Feb 2021

Spark Therapeutics launches gene therapy clinical trial for late-onset Pompe disease

Pompe disease is a hereditary genetic disorder caused by a deficiency of acid alpha-glucosidase leading to build-up of glycogen in the lyosomes, which then causes cell damage in various tissues, in particular the heart, the muscles, the liver and the nervous system.

3 Feb 2021

Study reveals a deep digital health divide within the older population

The COVID-19 pandemic is a great example of the importance of access to the Internet and to digital health information.

3 Feb 2021

Study examines link between health literacy and actionable memory for medication-taking

It is important for patients to understand the information they need for making health decisions, yet studies have shown that a large segment of the population lacks the health literacy to do so.

3 Feb 2021

Preclinical study uncovers how Zika virus passes from mother to fetus during pregnancy

A preclinical study by a University of South Florida Health Morsani College of Medicine research team has discovered a new mechanism for how Zika virus can pass from mothers to their children during pregnancy - a process known as vertical transmission.

3 Feb 2021

How well do fabric face masks protect from COVID?

In a new study, published on the pre-print server medRxiv, researchers at the University of Cambridge found that fabric face masks block 62.6 percent to 87.1 percent of fine particles, making them useful tools in the battle against the COVID-19 pandemic.

3 Feb 2021

Clinical trials of new treatments for COVID-19 often do not include vulnerable populations

Studies examining the effectiveness of treatments for COVID-19 often do not include the very populations hardest hit by the disease, according to a new review by University of Chicago Medicine researchers.

3 Feb 2021

Early use of therapeutic anticoagulation does not improve survival of critically ill COVID-19 patients

Although abnormal blood clotting has been identified as one of the primary causes of death from COVID-19, early treatment in an intensive care unit (ICU) with therapeutic anticoagulation (anti-clotting) for adults who are critically ill with COVID-19 does not appear to improve chances of survival, and could do more harm than good by increasing the risk for major bleeding, a multicenter research group cautions.

3 Feb 2021

Phase 1 clinical trial of novel HIV vaccine approach shows promising results

A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced today.

3 Feb 2021

Latest clinical trial supports UK’s decision to delay second COVID vaccine dose

Researchers in the UK, South Africa and Brazil have reported the latest efficacy results from phase III trials of the Oxford–AstraZeneca vaccine currently being rolled out in the UK to protect against coronavirus disease 2019 (COVID-19).

3 Feb 2021

Dispelling vaccine misinformation and myths in California’s breadbasket

Dust swirled in the air as Luz Gallegos parked her SUV on the side of a dirt road. She had just learned that her aunt died of covid-19 — the third family member to succumb to the disease in only two weeks.

3 Feb 2021

Biomarkers could help discriminate cancer therapy-associated kidney injury from other causes

A study by Mayo Clinic researchers published in Kidney International Reports finds that immune checkpoint inhibitors, may have negative consequences in some patients, including acute kidney inflammation, known as interstitial nephritis. Immune checkpoint inhibitors are used to treat cancer by stimulating the immune system to attack cancerous cells.

3 Feb 2021

Viral load the main driver of SARS-CoV-2 transmission

A study conducted by researchers in the UK and Spain suggests that viral load is the main determinant of transmission risk in cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

3 Feb 2021

Experimental intranasal influenza vaccine produces durable immune response

An experimental single-dose, intranasal influenza vaccine was safe and produced a durable immune response when tested in a Phase 1 study published in the Journal of Clinical Investigation.

3 Feb 2021

Medical News

NeuroVision Imaging receives ADDF funding to develop biomarker tests for Alzheimer's disease

Insight into role of aging in response to SARS-CoV-2 infection

Newly launched medical truck brings the emergency room to cardiac arrest patients

Rescheduling drugs can reduce use as well as the dangers, study finds

New drug cocktail offers hope to patients with highly drug-resistant tuberculosis

COVID-19 vaccine should be recommended to patients with Parkinson’s disease, experts say

Exploring the living quality in high-density housing

Spark Therapeutics launches gene therapy clinical trial for late-onset Pompe disease

Study reveals a deep digital health divide within the older population

Study examines link between health literacy and actionable memory for medication-taking

Preclinical study uncovers how Zika virus passes from mother to fetus during pregnancy

How well do fabric face masks protect from COVID?

Clinical trials of new treatments for COVID-19 often do not include vulnerable populations

Early use of therapeutic anticoagulation does not improve survival of critically ill COVID-19 patients

Phase 1 clinical trial of novel HIV vaccine approach shows promising results

Latest clinical trial supports UK’s decision to delay second COVID vaccine dose

Dispelling vaccine misinformation and myths in California’s breadbasket

Biomarkers could help discriminate cancer therapy-associated kidney injury from other causes

Viral load the main driver of SARS-CoV-2 transmission

Experimental intranasal influenza vaccine produces durable immune response

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News